RCMI Coordinating Center (RCMI CC) Header Logo

Josiah Ochieng

TitlePhD
Faculty RankProfessor
InstitutionMeharry Medical College
DepartmentBiochem, Cancer Biology, Neuroscience & Pharmacology
Address_1005 D.B. Todd Blvd.,
Nashville, TN 37208
Nashville TN 37208
Phone6153276119
vCardDownload vCard
    Other Positions
    TitleAdjunct Professor
    InstitutionVanderbilt University
    DepartmentCancer Biology


    Collapse Affiliation 

    Collapse Overview 
    Collapse overview
    My laboratory has investigated the potential role of fetuin-A (also known as alpha 2HS glycoprotein) in tumor progression for the past 20 years. In 2013, we demonstrated and reported that fetuin-A drives the progression of head and neck squamous cell carcinomas. More recently a number of studies have indicated that fetuin-A is up-regulated in a number of solid tumors including pancreatic, breast and prostate tumors. We have now demonstrated (published data) that fetuin-A is a major driver of growth and metastasis in glioblastomas. We will soon embark on pre-clinical studies using mouse models for glioblastomas. This study is of immense interest to us and we would like to engage as many collaborators as possible. Currently our focus is to determine the mechanisms by which fetuin-A modifies adhesion and growth competent exosomes during tumor growth and metastasis. I am also interested in looking at the role of fetuin-A in prostate cancer progression. This disease disproportionately affects men of African descent.

    Collapse Research 
    Collapse research activities and funding
    K14CA068281     (OCHIENG, JOSIAH)Aug 1, 1995 - Jul 31, 2002
    NIH
    INTERACTIONS OF GELATINASES WITH SERUM/MEMBRANE PROTEIN
    Role: Principal Investigator
    SC1CA134018     (OCHIENG, JOSIAH)Sep 19, 2007 - Dec 31, 2013
    NIH
    Role of Fetuin-A in Tumor Cell Growth
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ochieng J, Korolkova OY, Li G, Jin R, Chen Z, Matusik RJ, Adunyah S, Sakwe AM, Ogunkua O. Fetuin-A Promotes 3-Dimensional Growth in LNCaP Prostate Cancer Cells by Sequestering Extracellular Vesicles to Their Surfaces to Act as Signaling Platforms. Int J Mol Sci. 2022 Apr 05; 23(7). PMID: 35409390.
      Citations: 2     Fields:    Translation:HumansCells
    2. Beasley HK, Widatalla SE, Whalen DS, Williams SD, Korolkova OY, Namba C, Pratap S, Ochieng J, Sakwe AM. Identification of MAGEC2/CT10 as a High Calcium-Inducible Gene in Triple-Negative Breast Cancer. Front Endocrinol (Lausanne). 2022; 13:816598. PMID: 35355564.
      Citations:    Fields:    Translation:HumansCells
    3. Kanagasabai T, Li G, Shen TH, Gladoun N, Castillo-Martin M, Celada SI, Xie Y, Brown LK, Mark ZA, Ochieng J, Ballard BR, Cordon-Cardo C, Adunyah SE, Jin R, Matusik RJ, Chen Z. MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway. Cancer Lett. 2022 01 28; 525:46-54. PMID: 34610416.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    4. Thomas PL, Nangami G, Rana T, Evans A, Williams SD, Crowell D, Shanker A, Sakwe AM, Ochieng J. The rapid endocytic uptake of fetuin-A by adherent tumor cells is mediated by Toll-like receptor 4 (TLR4). FEBS Open Bio. 2020 12; 10(12):2722-2732. PMID: 33073533.
      Citations:    Fields:    Translation:HumansCells
    5. Korolkova OY, Widatalla SE, Williams SD, Whalen DS, Beasley HK, Ochieng J, Grewal T, Sakwe AM. Diverse Roles of Annexin A6 in Triple-Negative Breast Cancer Diagnosis, Prognosis and EGFR-Targeted Therapies. Cells. 2020 08 07; 9(8). PMID: 32784650.
      Citations: 14     Fields:    Translation:HumansCells
    6. Korolkova OY, Widatalla SE, Whalen DS, Nangami GN, Abimbola A, Williams SD, Beasley HK, Reisenbichler E, Washington MK, Ochieng J, Mayer IA, Lehmann BD, Sakwe AM. Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsets. PLoS One. 2020; 15(4):e0231711. PMID: 32298357.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    7. Widatalla SE, Korolkova OY, Whalen DS, Goodwin JS, Williams KP, Ochieng J, Sakwe AM. Lapatinib-induced annexin A6 upregulation as an adaptive response of triple-negative breast cancer cells to EGFR tyrosine kinase inhibitors. Carcinogenesis. 2019 08 22; 40(8):998-1009. PMID: 30590459.
      Citations: 16     Fields:    Translation:HumansCells
    8. Whalen DS, Widatalla SE, Korolkova OY, Nangami GS, Beasley HK, Williams SD, Virgous C, Lehmann BD, Ochieng J, Sakwe AM. Implication of calcium activated RasGRF2 in Annexin A6-mediated breast tumor cell growth and motility. Oncotarget. 2019 Jan 04; 10(2):133-151. PMID: 30719209.
      Citations: 9     Fields:    
    9. Ochieng J, Nangami G, Sakwe A, Rana T, Ingram S, Goodwin JS, Moye C, Lammers P, Adunyah SE. Extracellular histones are the ligands for the uptake of exosomes and hydroxyapatite-nanoparticles by tumor cells via syndecan-4. FEBS Lett. 2018 10; 592(19):3274-3285. PMID: 30179249.
      Citations: 16     Fields:    Translation:HumansCells
    10. Ochieng J, Nangami G, Sakwe A, Moye C, Alvarez J, Whalen D, Thomas P, Lammers P. Impact of Fetuin-A (AHSG) on Tumor Progression and Type 2 Diabetes. Int J Mol Sci. 2018 Jul 29; 19(8). PMID: 30060600.
      Citations: 23     Fields:    Translation:HumansAnimals
    11. Wang L, Widatalla SE, Whalen DS, Ochieng J, Sakwe AM. Association of calcium sensing receptor polymorphisms at rs1801725 with circulating calcium in breast cancer patients. BMC Cancer. 2017 Aug 02; 17(1):511. PMID: 28764683.
      Citations: 10     Fields:    Translation:Humans
    12. Nangami GN, Sakwe AM, Izban MG, Rana T, Lammers PE, Thomas P, Chen Z, Ochieng J. Fetuin-A (alpha 2HS glycoprotein) modulates growth, motility, invasion, and senescence in high-grade astrocytomas. Cancer Med. 2016 12; 5(12):3532-3543. PMID: 27882696.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    13. Higginbotham JN, Zhang Q, Jeppesen DK, Scott AM, Manning HC, Ochieng J, Franklin JL, Coffey RJ. Identification and characterization of EGF receptor in individual exosomes by fluorescence-activated vesicle sorting. J Extracell Vesicles. 2016; 5:29254. PMID: 27345057.
      Citations: 57     Fields:    
    14. Ochieng J, Nangami GN, Ogunkua O, Miousse IR, Koturbash I, Odero-Marah V, McCawley LJ, Nangia-Makker P, Ahmed N, Luqmani Y, Chen Z, Papagerakis S, Wolf GT, Dong C, Zhou BP, Brown DG, Colacci AM, Hamid RA, Mondello C, Raju J, Ryan EP, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Amedei A, Al-Temaimi R, Al-Mulla F, Bisson WH, Eltom SE. The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis. Carcinogenesis. 2015 Jun; 36 Suppl 1:S128-59. PMID: 26106135.
      Citations: 18     Fields:    Translation:HumansAnimalsPHPublic Health
    15. Goodson WH, Lowe L, Carpenter DO, Gilbertson M, Manaf Ali A, Lopez de Cerain Salsamendi A, Lasfar A, Carnero A, Azqueta A, Amedei A, Charles AK, Collins AR, Ward A, Salzberg AC, Colacci A, Olsen AK, Berg A, Barclay BJ, Zhou BP, Blanco-Aparicio C, Baglole CJ, Dong C, Mondello C, Hsu CW, Naus CC, Yedjou C, Curran CS, Laird DW, Koch DC, Carlin DJ, Felsher DW, Roy D, Brown DG, Ratovitski E, Ryan EP, Corsini E, Rojas E, Moon EY, Laconi E, Marongiu F, Al-Mulla F, Chiaradonna F, Darroudi F, Martin FL, Van Schooten FJ, Goldberg GS, Wagemaker G, Nangami GN, Calaf GM, Williams G, Wolf GT, Koppen G, Brunborg G, Lyerly HK, Krishnan H, Ab Hamid H, Yasaei H, Sone H, Kondoh H, Salem HK, Hsu HY, Park HH, Koturbash I, Miousse IR, Scovassi AI, Klaunig JE, Vondr?cek J, Raju J, Roman J, Wise JP, Whitfield JR, Woodrick J, Christopher JA, Ochieng J, Martinez-Leal JF, Weisz J, Kravchenko J, Sun J, Prudhomme KR, Narayanan KB, Cohen-Solal KA, Moorwood K, Gonzalez L, Soucek L, Jian L, D'Abronzo LS, Lin LT, Li L, Gulliver L, McCawley LJ, Memeo L, Vermeulen L, Leyns L, Zhang L, Valverde M, Khatami M, Romano MF, Chapellier M, Williams MA, Wade M, Manjili MH, Lleonart ME, Xia M, Gonzalez MJ, Karamouzis MV, Kirsch-Volders M, Vaccari M, Kuemmerle NB, Singh N, Cruickshanks N, Kleinstreuer N, van Larebeke N, Ahmed N, Ogunkua O, Krishnakumar PK, Vadgama P, Marignani PA, Ghosh PM, Ostrosky-Wegman P, Thompson PA, Dent P, Heneberg P, Darbre P, Sing Leung P, Nangia-Makker P, Cheng QS, Robey RB, Al-Temaimi R, Roy R, Andrade-Vieira R, Sinha RK, Mehta R, Vento R, Di Fiore R, Ponce-Cusi R, Dornetshuber-Fleiss R, Nahta R, Castellino RC, Palorini R, Abd Hamid R, Langie SA, Eltom SE, Brooks SA, Ryeom S, Wise SS, Bay SN, Harris SA, Papagerakis S, Romano S, Pavanello S, Eriksson S, Forte S, Casey SC, Luanpitpong S, Lee TJ, Otsuki T, Chen T, Massfelder T, Sanderson T, Guarnieri T, Hultman T, Dormoy V, Odero-Marah V, Sabbisetti V, Maguer-Satta V, Rathmell WK, Engstr?m W, Decker WK, Bisson WH, Rojanasakul Y, Luqmani Y, Chen Z, Hu Z. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead. Carcinogenesis. 2015 Jun; 36 Suppl 1:S254-96. PMID: 26106142.
      Citations: 85     Fields:    Translation:HumansAnimalsPHPublic Health
    16. Nangami G, Koumangoye R, Shawn Goodwin J, Sakwe AM, Marshall D, Higginbotham J, Ochieng J. Fetuin-A associates with histones intracellularly and shuttles them to exosomes to promote focal adhesion assembly resulting in rapid adhesion and spreading in breast carcinoma cells. Exp Cell Res. 2014 Nov 01; 328(2):388-400. PMID: 25194507.
      Citations: 22     Fields:    Translation:HumansCells
    17. Koumangoye RB, Nangami GN, Thompson PD, Agboto VK, Ochieng J, Sakwe AM. Reduced annexin A6 expression promotes the degradation of activated epidermal growth factor receptor and sensitizes invasive breast cancer cells to EGFR-targeted tyrosine kinase inhibitors. Mol Cancer. 2013 Dec 19; 12(1):167. PMID: 24354805.
      Citations: 30     Fields:    Translation:HumansCells
    18. Thompson PD, Sakwe A, Koumangoye R, Yarbrough WG, Ochieng J, Marshall DR. Alpha-2 Heremans Schmid Glycoprotein (AHSG) modulates signaling pathways in head and neck squamous cell carcinoma cell line SQ20B. Exp Cell Res. 2014 Feb 15; 321(2):123-32. PMID: 24332981.
      Citations: 11     Fields:    Translation:HumansCells
    19. Nangami GN, Watson K, Parker-Johnson K, Okereke KO, Sakwe A, Thompson P, Frimpong N, Ochieng J. Fetuin-A (a2HS-glycoprotein) is a serum chemo-attractant that also promotes invasion of tumor cells through Matrigel. Biochem Biophys Res Commun. 2013 Sep 06; 438(4):660-5. PMID: 23933250.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    20. Johnson KP, Yearby LA, Stoute D, Burow ME, Rhodes LV, Gray M, Carriere P, Tilghman SL, McLachlan JA, Ochieng J. In vitro and in vivo evaluation of novel anticancer agents in triple negative breast cancer models. J Health Care Poor Underserved. 2013 Feb; 24(1 Suppl):104-11. PMID: 23395947.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    21. Watson K, Koumangoye R, Thompson P, Sakwe AM, Patel T, Pratap S, Ochieng J. Fetuin-A triggers the secretion of a novel set of exosomes in detached tumor cells that mediate their adhesion and spreading. FEBS Lett. 2012 Sep 21; 586(19):3458-63. PMID: 22980907.
      Citations: 21     Fields:    Translation:HumansCells
    22. Koumangoye RB, Sakwe AM, Goodwin JS, Patel T, Ochieng J. Detachment of breast tumor cells induces rapid secretion of exosomes which subsequently mediate cellular adhesion and spreading. PLoS One. 2011; 6(9):e24234. PMID: 21915303.
      Citations: 107     Fields:    Translation:HumansCells
    23. Sakwe AM, Koumangoye R, Guillory B, Ochieng J. Annexin A6 contributes to the invasiveness of breast carcinoma cells by influencing the organization and localization of functional focal adhesions. Exp Cell Res. 2011 Apr 01; 317(6):823-37. PMID: 21185831.
      Citations: 42     Fields:    Translation:HumansCells
    24. Sakwe AM, Koumangoye R, Goodwin SJ, Ochieng J. Fetuin-A ({alpha}2HS-glycoprotein) is a major serum adhesive protein that mediates growth signaling in breast tumor cells. J Biol Chem. 2010 Dec 31; 285(53):41827-35. PMID: 20956534.
      Citations: 31     Fields:    Translation:HumansCells
    25. Guillory B, Sakwe AM, Saria M, Thompson P, Adhiambo C, Koumangoye R, Ballard B, Binhazim A, Cone C, Jahanen-Dechent W, Ochieng J. Lack of fetuin-A (alpha2-HS-glycoprotein) reduces mammary tumor incidence and prolongs tumor latency via the transforming growth factor-beta signaling pathway in a mouse model of breast cancer. Am J Pathol. 2010 Nov; 177(5):2635-44. PMID: 20847285.
      Citations: 20     Fields:    Translation:HumansAnimalsCells
    26. Ochieng J, Chaudhuri G. Cystatin superfamily. J Health Care Poor Underserved. 2010 Feb; 21(1 Suppl):51-70. PMID: 20173285.
      Citations: 60     Fields:    Translation:Humans
    27. Ochieng J, Pratap S, Khatua AK, Sakwe AM. Anchorage-independent growth of breast carcinoma cells is mediated by serum exosomes. Exp Cell Res. 2009 Jul 01; 315(11):1875-88. PMID: 19327352.
      Citations: 46     Fields:    Translation:HumansCells
    28. Baptiste TA, James A, Saria M, Ochieng J. Mechano-transduction mediated secretion and uptake of galectin-3 in breast carcinoma cells: implications in the extracellular functions of the lectin. Exp Cell Res. 2007 Feb 15; 313(4):652-64. PMID: 17184769.
      Citations: 23     Fields:    Translation:HumansCells
    29. Lukyanov P, Furtak V, Ochieng J. Galectin-3 interacts with membrane lipids and penetrates the lipid bilayer. Biochem Biophys Res Commun. 2005 Dec 16; 338(2):1031-6. PMID: 16248982.
      Citations: 21     Fields:    Translation:AnimalsCells
    30. Kundranda MN, Henderson M, Carter KJ, Gorden L, Binhazim A, Ray S, Baptiste T, Shokrani M, Leite-Browning ML, Jahnen-Dechent W, Matrisian LM, Ochieng J. The serum glycoprotein fetuin-A promotes Lewis lung carcinoma tumorigenesis via adhesive-dependent and adhesive-independent mechanisms. Cancer Res. 2005 Jan 15; 65(2):499-506. PMID: 15695392.
      Citations: 27     Fields:    Translation:AnimalsCells
    31. Kleshchenko YY, Moody TN, Furtak VA, Ochieng J, Lima MF, Villalta F. Human galectin-3 promotes Trypanosoma cruzi adhesion to human coronary artery smooth muscle cells. Infect Immun. 2004 Nov; 72(11):6717-21. PMID: 15501810.
      Citations: 40     Fields:    Translation:HumansAnimalsCells
    32. Kundranda MN, Ray S, Saria M, Friedman D, Matrisian LM, Lukyanov P, Ochieng J. Annexins expressed on the cell surface serve as receptors for adhesion to immobilized fetuin-A. Biochim Biophys Acta. 2004 Aug 23; 1693(2):111-23. PMID: 15313013.
      Citations: 22     Fields:    Translation:HumansCells
    33. Leite-Browning ML, McCawley LJ, Jahnen-Dechent W, King LE, Matrisian LM, Ochieng J. Alpha 2-HS glycoprotein (fetuin-A) modulates murine skin tumorigenesis. Int J Oncol. 2004 Aug; 25(2):319-24. PMID: 15254728.
      Citations: 2     Fields:    Translation:Animals
    34. Ray S, Lukyanov P, Ochieng J. Members of the cystatin superfamily interact with MMP-9 and protect it from autolytic degradation without affecting its gelatinolytic activities. Biochim Biophys Acta. 2003 Dec 01; 1652(2):91-102. PMID: 14644044.
      Citations: 19     Fields:    Translation:HumansAnimals
    35. Leite-Browning ML, McCawley LJ, Choi OH, Matrisian LM, Ochieng J. Interactions of alpha2-HS-glycoprotein (fetuin) with MMP-3 and murine squamous cell carcinoma cells. Int J Oncol. 2002 Nov; 21(5):965-71. PMID: 12370742.
      Citations: 5     Fields:    Translation:AnimalsCells
    36. Ochieng J, Furtak V, Lukyanov P. Extracellular functions of galectin-3. Glycoconj J. 2002; 19(7-9):527-35. PMID: 14758076.
      Citations: 143     Fields:    Translation:HumansAnimalsCells
    37. Furtak V, Hatcher F, Ochieng J. Galectin-3 mediates the endocytosis of beta-1 integrins by breast carcinoma cells. Biochem Biophys Res Commun. 2001 Dec 14; 289(4):845-50. PMID: 11735123.
      Citations: 65     Fields:    Translation:HumansCells
    38. Zhu WQ, Ochieng J. Rapid release of intracellular galectin-3 from breast carcinoma cells by fetuin. Cancer Res. 2001 Mar 01; 61(5):1869-73. PMID: 11280740.
      Citations: 12     Fields:    Translation:HumansCells
    39. Moody TN, Ochieng J, Villalta F. Novel mechanism that Trypanosoma cruzi uses to adhere to the extracellular matrix mediated by human galectin-3. FEBS Lett. 2000 Mar 31; 470(3):305-8. PMID: 10745086.
      Citations: 39     Fields:    Translation:HumansAnimalsCells
    40. Ochieng J, Warfield P, Green-Jarvis B, Fentie I. Galectin-3 regulates the adhesive interaction between breast carcinoma cells and elastin. J Cell Biochem. 1999 Dec 01; 75(3):505-14. PMID: 10536372.
      Citations: 32     Fields:    Translation:HumansCells
    41. Ochieng J, Leite-Browning ML, Warfield P. Regulation of cellular adhesion to extracellular matrix proteins by galectin-3. Biochem Biophys Res Commun. 1998 May 29; 246(3):788-91. PMID: 9618290.
      Citations: 66     Fields:    Translation:HumansAnimalsCells
    42. Ochieng J, Green B, Evans S, James O, Warfield P. Modulation of the biological functions of galectin-3 by matrix metalloproteinases. Biochim Biophys Acta. 1998 Jan 08; 1379(1):97-106. PMID: 9468337.
      Citations: 55     Fields:    Translation:HumansAnimalsCells
    43. Ochieng J, Warfield P, Johnson KN. Establishment of breast cell cultures and lines from peoples of African origin. Am J Obstet Gynecol. 1997 Jun; 176(6):S240-5. PMID: 9215215.
      Citations: 2     Fields:    Translation:HumansCells
    44. Warfield PR, Makker PN, Raz A, Ochieng J. Adhesion of human breast carcinoma to extracellular matrix proteins is modulated by galectin-3. Invasion Metastasis. 1997; 17(2):101-12. PMID: 9561029.
      Citations: 20     Fields:    Translation:HumansCells
    45. Ochieng J, Green B. The interactions of alpha 2HS glycoprotein with metalloproteinases. Biochem Mol Biol Int. 1996 Sep; 40(1):13-20. PMID: 8886265.
      Citations: 2     Fields:    Translation:HumansAnimals
    46. Johnson DE, Ochieng J, Evans SL. Phenylacetic acid halides inhibit estrogen receptor (ER)-positive MCF-7 cells, but not ER-negative human breast cancer cells or normal breast epithelial cells. Anticancer Drugs. 1996 May; 7(3):288-92. PMID: 8792002.
      Citations: 2     Fields:    Translation:HumansCells
    47. Ochieng J, Warfield P. Galectin-3 binding potentials of mouse tumor EHS and human placental laminins. Biochem Biophys Res Commun. 1995 Dec 14; 217(2):402-6. PMID: 7503714.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    48. Nangiamakker P, Thompson E, Hogan C, Ochieng J, Raz A. Induction of tumorigenicity by galectin-3 in a nontumorigenic human breast-carcinoma cell-line. Int J Oncol. 1995 Nov; 7(5):1079-87. PMID: 21552935.
      Citations: 18     Fields:    
    49. Ochieng J, Warfield P, Green B. Interactions of gelatinases with soluble and immobilized fetuin and asialofetuin. Arch Biochem Biophys. 1995 Sep 10; 322(1):250-5. PMID: 7574683.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    50. Johnson DE, Ochieng J, Evans SL. The growth inhibitory properties of a dopamine agonist (SKF 38393) on MCF-7 cells. Anticancer Drugs. 1995 Jun; 6(3):471-4. PMID: 7670147.
      Citations: 11     Fields:    Translation:HumansCells
    51. Ochieng J, Fridman R, Nangia-Makker P, Kleiner DE, Liotta LA, Stetler-Stevenson WG, Raz A. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry. 1994 Nov 29; 33(47):14109-14. PMID: 7947821.
      Citations: 117     Fields:    Translation:HumansCells
    52. Nangia-Makker P, Ochieng J, Christman JK, Raz A. Regulation of the expression of galactoside-binding lectin during human monocytic differentiation. Cancer Res. 1993 Oct 15; 53(20):5033-7. PMID: 8402696.
      Citations: 6     Fields:    Translation:HumansCells
    53. Ochieng J, Gerold M, Raz A. Dichotomy in the laminin-binding properties of soluble and membrane-bound human galactoside-binding protein. Biochem Biophys Res Commun. 1992 Aug 14; 186(3):1674-80. PMID: 1510690.
      Citations: 4     Fields:    Translation:HumansCells
    54. Ochieng J, Tahin QS, Booth CC, Russo J. Buffering of intracellular calcium in response to increased extracellular levels in mortal, immortal, and transformed human breast epithelial cells. J Cell Biochem. 1991 Jul; 46(3):250-4. PMID: 1774225.
      Citations: 4     Fields:    Translation:HumansCells
    55. Ochieng J, Basolo F, Albini A, Melchiori A, Watanabe H, Elliott J, Raz A, Parodi S, Russo J. Increased invasive, chemotactic and locomotive abilities of c-Ha-ras-transformed human breast epithelial cells. Invasion Metastasis. 1991; 11(1):38-47. PMID: 2061003.
      Citations: 13     Fields:    Translation:HumansAnimals
    56. Ochieng J, Tait L, Russo J. Calcium-mediated modulation of microtubule assembly in human breast epithelial cells. In Vitro Cell Dev Biol. 1990 Apr; 26(4):318-24. PMID: 2160923.
      Citations: 2     Fields:    Translation:HumansCells
    57. Muralidhar G, Ochieng J, Trewyn RW. Altered queuine modification of transfer RNA involved in the in vitro transformation of Chinese hamster embryo cells. Cancer Res. 1989 Dec 15; 49(24 Pt 1):7110-4. PMID: 2582452.
      Citations: 3     Fields:    Translation:AnimalsCells
    58. Ochieng J, Patrick DE, Utz ED, Trewyn RW. Inhibition of phorbol ester-mediated phenotypic changes in cultured cells by hypoxanthine. Carcinogenesis. 1987 Nov; 8(11):1629-33. PMID: 3664954.
      Citations:    Fields:    Translation:HumansAnimalsCells
    Ochieng's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (293)
    Explore
    _
    Co-Authors (15)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support